Press Releases

Read our latest announcements

Filter by year:

2019-01-29
Modus Therapeutics strengthens Board with two key appointments

STOCKHOLM, SWEDEN – 29 January 2019: Modus Therapeutics AB, a company developing innovative treatments in high unmet medical need disease areas with a focus on sickle cell disease (SCD), announcesthe appointment of two new Board members. Stig Løkke Pedersen, an experienced life science industry veteran with more than 30 years’ experience, has been appointed Chairman […]

View Press Release